by The global biopharmaceutical third party logistics market size is expected to be worth around US$ 150.2 billion by 2030, according to a new report by Vision Research Reports.
The global biopharmaceutical third party logistics market size was valued at US$ 96.4 billion in 2020 and is anticipated to grow at a CAGR of 6.6% during forecast period 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38820
Table of Contents
Biopharmaceutical Third Party Logistics Market Growth Factors
The rising trend of outsourcing logistics, the focus of pharmaceutical players on their distribution network owing to its strong sales numbers, and the rise in the number of biosimilar launches are some of the key factors driving the market.
hese advanced vehicles are designed to automate and provide temperature control systems during transportation that help in reducing complexities, human error, and damage to products in transit. Thus, these monitoring solutions allow visibility that can converse breaches through automatic alerts by providing information to execute contingency plans.
Biopharmaceutical Third Party Logistics Market Report Coverage
| Report Scope | Details |
| Market Size | US$ 150.2 Bn by 2030 |
| Growth Rate | CAGR of 6.6% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Supply chain, service type |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | DHL International GmbH.; SF Express; United Parcel Service of America, Inc.; AmerisourceBergen Corporation; DB Schenker; Kuehne and Nagel; Kerry logistics network limited; Agility |
By Supply Chain Analysis
the non-cold chain logistics segment dominated the market for biopharmaceutical third-party logistics (3PL) and contributed to the largest revenue share of 80.8%. This is owing to an increase in pharmaceutical sales through distributors. 3PL services provide greater scalability, higher visibility, reduce overall operating costs, and help develop a stronger logistics network with higher returns and lower risks.
The cold chain is projected to be the fastest-growing supply chain segment with a CAGR of 9.6% in the market for biopharmaceutical third-party logistics (3PL) over the forecast period. This is majorly owing to the rising demand for a new class of drugs, called biologics that have shown tremendous growth over the past few years.
By Service Type Analysis
the warehousing and storage segment dominated the market for biopharmaceutical third-party logistics (3PL) and held the largest revenue share of 43.6%. This is attributed to a large demand for 3PL services from the pharmaceutical and healthcare industry.
The other segment is projected to expand at a lucrative CAGR of 6.4% in the market for biopharmaceutical third-party logistics (3PL) over the forecast period. Packaging, custom and duty management, procurement services, and a few other values added services are included in this segment.
By Regional Analysis
North America dominated the biopharmaceutical third-party logistics (3PL) market and accounted for the largest revenue share of 41.5% in 2020. This is majorly attributed to the dominance of the region in the biologics and pharmaceutical drugs market and an increase in exports and imports for biopharmaceuticals.
In Asia Pacific, the market for biopharmaceutical third-party logistics (3PL) witnessed the second largest revenue of USD 15.4 billion in 2020 and is also expected to witness the fastest CAGR of 7.2% over the forecast period.
Read also @ Cancer Immunotherapy Market Opportunities & Forecast 2021-2030
Major Key Players Covered in The Biopharmaceutical Third Party Logistics Market Report include
- FedEx.
- DHL International GmbH
- SF Express
- United Parcel Service of America, Inc.
- AmerisourceBergen Corporation
- DB Schenker
- KUEHNE + NAGEL
- Kerry Logistics Network Limited
- Agility
Biopharmaceutical Third Party Logistics Market Segmentation
- By Supply Chain
- Cold Chain
- Non-cold Chain
- By Service Type
- Transportation
- Air Freight
- Sea Freight
- Overland
- Warehousing and Storage
- Others
- Transportation
- Regional
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- U.K.
- Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Biopharmaceutical Third Party Logistics Market Snapshot
Chapter 4. Biopharmaceutical Third Party Logistics Market Variables and Scope
4.1. Introduction
4.2. Biopharmaceutical Third Party Logistics Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Biopharmaceutical Third Party Logistics Market Dynamics Analysis and Trends
5.1. Biopharmaceutical Third Party Logistics Market Dynamics
5.1.1. Biopharmaceutical Third Party Logistics Market Drivers
5.1.2. Biopharmaceutical Third Party Logistics Market Restraints
5.1.3. Biopharmaceutical Third Party Logistics Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Biopharmaceutical Third Party Logistics Market, By Supply Chain
7.1. Biopharmaceutical Third Party Logistics Market, by Supply Chain, 2021-2030
7.1.1. Cold Chain
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Non-cold Chain
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Biopharmaceutical Third Party Logistics Market, By Service Type
8.1. Biopharmaceutical Third Party Logistics Market, by Service Type, 2021-2030
8.1.1. Transportation
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Warehousing and Storage
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Biopharmaceutical Third Party Logistics Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.1.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.1.3.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.1.4.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.2.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.2.3.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.2.4.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.2.5.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.2.6.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.3.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.3.3.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.3.4.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.3.5.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.3.6.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.4.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.4.3.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.4.4.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.4.5.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.4.6.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.5.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.5.3.2. Market Revenue and Forecast, by Service Type (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Supply Chain (2017-2030)
9.5.4.2. Market Revenue and Forecast, by Service Type (2017-2030)
Chapter 10. Company Profiles
10.1. FedEx.
10.1.1. Company Overview
10.1.2. Supply Chain Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. DHL International GmbH
10.2.1. Company Overview
10.2.2. Supply Chain Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. SF Express
10.3.1. Company Overview
10.3.2. Supply Chain Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. United Parcel Service of America, Inc.
10.4.1. Company Overview
10.4.2. Supply Chain Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. AmerisourceBergen Corporation
10.5.1. Company Overview
10.5.2. Supply Chain Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. DB Schenker
10.6.1. Company Overview
10.6.2. Supply Chain Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. KUEHNE + NAGEL
10.7.1. Company Overview
10.7.2. Supply Chain Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Kerry Logistics Network Limited
10.8.1. Company Overview
10.8.2. Supply Chain Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Agility
10.9.1. Company Overview
10.9.2. Supply Chain Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38820
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
